Le Lézard
Classified in: Health, Science and technology, Business
Subjects: NPT, TDS, CSR

FII 5th Anniversary Brings Together 250+ Leaders to Invest in Humanity


RIYADH, Saudi Arabia, Oct. 13, 2021 /CNW/ -- The 5th Anniversary of the Future Investment Initiative (FII), set to take place October 26 ? 28 in the Saudi capital Riyadh, is expected to see the announcement of a fresh round of agreements and investments, atop a total of US$125 billion in agreements that have been announced since the debut of FII in 2017.

With the platform now led by FII Institute, the vision is to empower the world's brightest minds to shape a brighter future for all. FII Institute has created a program that focuses action on the theme Invest in Humanity with deep dives into core areas that are driving business, government, and investment ? AI, Robotics, Education, Healthcare, and Sustainability.

FII Institute CEO Richard Attias said, "The 5th Anniversary of FII has been specifically designed to leverage the transformations of the past year to ensure progress, prosperity, and opportunity for all. FII's interactive program features conversations with global leaders, executive roundtables, and networking with CEOs and policymakers. What makes FII stand out is its commitment to turning conversations into actions, and that will continue this month as we create solutions to impact on humanity."

The platform will include interactive summits on Investing in Education; Investing in the Metaverse; and Investing in ESG as well as key sessions on the evolving role of business and government, investing in equality, investing in medical innovation, the circular carbon economy, adapting to climate change, as well as investing in food security, green hydrogen, and the future of clean energy start-ups.

More than 250 top international speakers have been confirmed to speak at FII including Governor of Saudi Arabia's Public Investment Fund and FII Institute Chairman H.E. Yasir Al-Rumayyan; Accor Chairman and CEO Sébastien Bazin; Banco Santander S.A. Group Executive Chairman Ana Patricia Botín; Thales Chairman and CEO Patrice Caine; Bridgewater Associates, LP, Co-Chairman & Co CIO Ray Dalio; BlackRock, Inc. Chairman & CEO Larry Fink; Ferretti Group CEO Alberto Galassi; BNY Mellon CEO Thomas P. (Todd) Gibbons; Global EDF Group Chairman and CEO Jean-Bernard Lévy; Milken Institute Chairman Michael Milken; and HSBC Holdings plc Group CEO Noel Quinn. Other speakers include:

For details visit: Fii-institute.org

About FII Institute 

FII Institute is a global nonprofit foundation with an investment arm and one agenda: Impact on Humanity. We are in the right place at the right time ? when decision makers, investors and youth come together in aspiration, energized and ready for change.

Photo - https://mma.prnewswire.com/media/1659635/FII_5th_Anniversary.jpg

SOURCE FII Institute


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: